SPIMACO

Saudi Pharmaceutical Industries & Medical Appliances Corp.

2070StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021	2020Dec 31, 2020
Operating Summary
Revenue	1.68B	1.66B	1.42B	1.46B	1.56B
Cost of Revenue	865.95M	965.80M	864.50M	846.73M	869.96M
Gross Profit	816.05M	689.64M	557.31M	613.05M	685.32M
SG&A	592.49M	615.47M	620.63M	551.26M	530.74M
R&D	76.39M	41.80M	42.65M	29.07M	20.35M
Operating Expenses	701.49M	629.92M	665.39M	580.22M	541.58M
Operating Income	114.56M	59.72M	-108.08M	32.83M	143.75M
Interest Income	7.66M	10.59M	—	—	7.00M
Interest Expense	-86.78M	-63.51M	-34.33M	-31.40M	-33.61M
Other Income/Expense	0.01M	-3.17M	—	-1.49M	0.30M
Pretax Income	72.01M	5.21M	-132.59M	33.73M	158.70M
Income Tax	40.17M	45.26M	25.90M	12.35M	43.90M
Net Income	24.54M	-50.73M	-165.14M	26.45M	124.79M
EBITDA	189.52M	131.34M	-28.21M	112.57M	222.17M
EBIT	114.56M	59.72M	-108.08M	32.83M	143.75M
EPS (Basic)	0.21	-0.42	-1.38	0.22	1.04
EPS (Diluted)	0.21	-0.42	-1.38	0.22	1.04
DPS	—	—	—	0.60	1.00
Margins & Efficiency
Gross Margin %	+48.5%	+41.7%	+39.2%	+42.0%	+44.1%
EBITDA Margin %	+11.3%	+7.9%	-2.0%	+7.7%	+14.3%
Net Margin %	+1.5%	-3.1%	-11.6%	+1.8%	+8.0%
Revenue & Income
Revenue	1.68B	1.66B	1.42B	1.46B	1.56B
Revenue Growth (YoY)	+1.6%	+16.4%	-2.6%	-6.1%	+4.6%
Interest & Investment Income	7.66M	10.59M	—	—	7.00M
Earnings From Equity Investments	22.73M	20.00M	20.44M	11.41M	38.21M
Gain (Loss) on Sale of Assets	18.94M	6.38M	0.14M	-0.45M	—
Gain (Loss) on Sale of Investments	—	—	3.63M	7.81M	3.52M
Currency Exchange Gain (Loss)	-10.16M	-4.32M	-14.38M	15.03M	-0.47M
Expenses & Provisions
Advertising Expenses	33.20M	56.75M	41.89M	40.43M	35.98M
Cost of Revenue	865.95M	965.80M	864.50M	846.73M	869.96M
Selling, General & Admin	592.49M	615.47M	620.63M	551.26M	530.74M
Research & Development	76.39M	41.80M	42.65M	29.07M	20.35M
Operating Expenses	701.49M	629.92M	665.39M	580.22M	541.58M
Other Operating Expenses	-4.44M	-69.39M	-7.93M	13.74M	-10.98M
Interest Expense	-86.78M	-63.51M	-34.33M	-31.40M	-33.61M
Other Non Operating Income (Expenses)	0.01M	-3.17M	—	-1.49M	0.30M
Legal Settlements	5.05M	-20.47M	—	—	—
D&A For EBITDA	74.96M	71.62M	79.87M	79.74M	78.43M
Profitability & Returns
Gross Profit	816.05M	689.64M	557.31M	613.05M	685.32M
Gross Margin	+48.5%	+41.7%	+39.2%	+42.0%	+44.1%
EBIT	114.56M	59.72M	-108.08M	32.83M	143.75M
EBIT Margin	+6.8%	+3.6%	-7.6%	+2.2%	+9.2%
EBITDA	189.52M	131.34M	-28.21M	112.57M	222.17M
EBITDA Margin	+11.3%	+7.9%	-2.0%	+7.7%	+14.3%
EBT Excluding Unusual Items	48.02M	19.30M	-136.35M	26.38M	155.18M
Pretax Income	72.01M	5.21M	-132.59M	33.73M	158.70M
Operating Income	114.56M	59.72M	-108.08M	32.83M	143.75M
Operating Margin	+6.8%	+3.6%	-7.6%	+2.2%	+9.2%
Profit Margin	+1.5%	-3.1%	-11.6%	+1.8%	+8.0%
Net Income	24.54M	-50.73M	-165.14M	26.45M	124.79M
Net Income to Common	24.54M	-50.73M	-165.14M	26.45M	124.79M
Net Income to Company	31.84M	-40.05M	-171.23M	18.10M	109.54M
Net Income Growth	—	—	—	-78.8%	—
Earnings From Continuing Ops.	31.84M	-40.05M	-158.48M	21.38M	114.81M
Earnings From Discontinued Ops.	—	—	-12.75M	-3.28M	-5.26M
Minority Interest in Earnings	-7.31M	-10.68M	6.10M	8.35M	15.25M
Income Tax Expense	40.17M	45.26M	25.90M	12.35M	43.90M
Effective Tax Rate	+55.8%	+868.2%	—	+36.6%	+27.7%
Per Share & Capital
EPS (Basic)	0.21	-0.42	-1.38	0.22	1.04
EPS (Diluted)	0.21	-0.42	-1.38	0.22	1.04
EPS Growth	—	—	—	-78.8%	—
Dividend Per Share	—	—	—	0.60	1.00
Shares Change (YoY)	-0	-0	—	—	—
Shares Outstanding (Basic)	119.53M	119.63M	120.00M	120.00M	120.00M
Shares Outstanding (Diluted)	119.53M	119.63M	120.00M	120.00M	120.00M
Dividend Growth	—	—	—	-40.0%	—
Free Cash Flow	-402.23M	-95.92M	-177.51M	10.47M	-155.02M
Free Cash Flow Margin	-23.9%	-5.8%	-12.5%	+0.7%	-10.0%
Free Cash Flow Per Share	-3.37	-0.80	-1.48	0.09	-1.29
Payout Ratio	+11.3%	—	—	+446.5%	+47.3%

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021	2020Dec 31, 2020
Operating Summary
Revenue	1.68B	1.66B	1.42B	1.46B	1.56B
Cost of Revenue	865.95M	965.80M	864.50M	846.73M	869.96M
Gross Profit	816.05M	689.64M	557.31M	613.05M	685.32M
SG&A	592.49M	615.47M	620.63M	551.26M	530.74M
R&D	76.39M	41.80M	42.65M	29.07M	20.35M
Operating Expenses	701.49M	629.92M	665.39M	580.22M	541.58M
Operating Income	114.56M	59.72M	-108.08M	32.83M	143.75M
Interest Income	7.66M	10.59M	—	—	7.00M
Interest Expense	-86.78M	-63.51M	-34.33M	-31.40M	-33.61M
Other Income/Expense	0.01M	-3.17M	—	-1.49M	0.30M
Pretax Income	72.01M	5.21M	-132.59M	33.73M	158.70M
Income Tax	40.17M	45.26M	25.90M	12.35M	43.90M
Net Income	24.54M	-50.73M	-165.14M	26.45M	124.79M
EBITDA	189.52M	131.34M	-28.21M	112.57M	222.17M
EBIT	114.56M	59.72M	-108.08M	32.83M	143.75M
EPS (Basic)	0.21	-0.42	-1.38	0.22	1.04
EPS (Diluted)	0.21	-0.42	-1.38	0.22	1.04
DPS	—	—	—	0.60	1.00
Margins & Efficiency
Gross Margin %	+48.5%	+41.7%	+39.2%	+42.0%	+44.1%
EBITDA Margin %	+11.3%	+7.9%	-2.0%	+7.7%	+14.3%
Net Margin %	+1.5%	-3.1%	-11.6%	+1.8%	+8.0%
Revenue & Income
Revenue	1.68B	1.66B	1.42B	1.46B	1.56B
Revenue Growth (YoY)	+1.6%	+16.4%	-2.6%	-6.1%	+4.6%
Interest & Investment Income	7.66M	10.59M	—	—	7.00M
Earnings From Equity Investments	22.73M	20.00M	20.44M	11.41M	38.21M
Gain (Loss) on Sale of Assets	18.94M	6.38M	0.14M	-0.45M	—
Gain (Loss) on Sale of Investments	—	—	3.63M	7.81M	3.52M
Currency Exchange Gain (Loss)	-10.16M	-4.32M	-14.38M	15.03M	-0.47M
Expenses & Provisions
Advertising Expenses	33.20M	56.75M	41.89M	40.43M	35.98M
Cost of Revenue	865.95M	965.80M	864.50M	846.73M	869.96M
Selling, General & Admin	592.49M	615.47M	620.63M	551.26M	530.74M
Research & Development	76.39M	41.80M	42.65M	29.07M	20.35M
Operating Expenses	701.49M	629.92M	665.39M	580.22M	541.58M
Other Operating Expenses	-4.44M	-69.39M	-7.93M	13.74M	-10.98M
Interest Expense	-86.78M	-63.51M	-34.33M	-31.40M	-33.61M
Other Non Operating Income (Expenses)	0.01M	-3.17M	—	-1.49M	0.30M
Legal Settlements	5.05M	-20.47M	—	—	—
D&A For EBITDA	74.96M	71.62M	79.87M	79.74M	78.43M
Profitability & Returns
Gross Profit	816.05M	689.64M	557.31M	613.05M	685.32M
Gross Margin	+48.5%	+41.7%	+39.2%	+42.0%	+44.1%
EBIT	114.56M	59.72M	-108.08M	32.83M	143.75M
EBIT Margin	+6.8%	+3.6%	-7.6%	+2.2%	+9.2%
EBITDA	189.52M	131.34M	-28.21M	112.57M	222.17M
EBITDA Margin	+11.3%	+7.9%	-2.0%	+7.7%	+14.3%
EBT Excluding Unusual Items	48.02M	19.30M	-136.35M	26.38M	155.18M
Pretax Income	72.01M	5.21M	-132.59M	33.73M	158.70M
Operating Income	114.56M	59.72M	-108.08M	32.83M	143.75M
Operating Margin	+6.8%	+3.6%	-7.6%	+2.2%	+9.2%
Profit Margin	+1.5%	-3.1%	-11.6%	+1.8%	+8.0%
Net Income	24.54M	-50.73M	-165.14M	26.45M	124.79M
Net Income to Common	24.54M	-50.73M	-165.14M	26.45M	124.79M
Net Income to Company	31.84M	-40.05M	-171.23M	18.10M	109.54M
Net Income Growth	—	—	—	-78.8%	—
Earnings From Continuing Ops.	31.84M	-40.05M	-158.48M	21.38M	114.81M
Earnings From Discontinued Ops.	—	—	-12.75M	-3.28M	-5.26M
Minority Interest in Earnings	-7.31M	-10.68M	6.10M	8.35M	15.25M
Income Tax Expense	40.17M	45.26M	25.90M	12.35M	43.90M
Effective Tax Rate	+55.8%	+868.2%	—	+36.6%	+27.7%
Per Share & Capital
EPS (Basic)	0.21	-0.42	-1.38	0.22	1.04
EPS (Diluted)	0.21	-0.42	-1.38	0.22	1.04
EPS Growth	—	—	—	-78.8%	—
Dividend Per Share	—	—	—	0.60	1.00
Shares Change (YoY)	-0	-0	—	—	—
Shares Outstanding (Basic)	119.53M	119.63M	120.00M	120.00M	120.00M
Shares Outstanding (Diluted)	119.53M	119.63M	120.00M	120.00M	120.00M
Dividend Growth	—	—	—	-40.0%	—
Free Cash Flow	-402.23M	-95.92M	-177.51M	10.47M	-155.02M
Free Cash Flow Margin	-23.9%	-5.8%	-12.5%	+0.7%	-10.0%
Free Cash Flow Per Share	-3.37	-0.80	-1.48	0.09	-1.29
Payout Ratio	+11.3%	—	—	+446.5%	+47.3%